The findings of this study indicate that not only can changes in the PI3K/AKT/mTOR pathway provide prognostic factors about survival, but also that genetic activation of the PI3K/AKT/mTOR pathway is an important characteristic of ovarian cancer. This evidence concerns the gene PIK3CB and ovarian carcinoma.